Latest return on equity
Nautilus Biotechnology Return on equity
Direct answer
Nautilus Biotechnology's return on equity is -36.21%.
The verified market snapshot reports -36.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 8, 2026.
Get free Nautilus Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -36.21%
Explore related company data
View Nautilus Biotechnology's market capitalizationView Nautilus Biotechnology's price-to-book ratioView Nautilus Biotechnology's 52-week price rangeView Nautilus Biotechnology's profit marginView Nautilus Biotechnology's debt-to-equity ratioView all Nautilus Biotechnology key metricsReturn to Nautilus Biotechnology profile